Noninvasive Detection of Lactate as a Biomarker of Response Using Spectral-Selective Multiple Quantum Editing Sequence (SS-SelMQC)
Abstract
This application focuses on enhancing cancer care by developing non-invasive techniques to determine better biomarkers to improve diagnostic specificity and decrease the number of negative biopsies, and also as markers of response with novel targeted agents such as Trastuzumab and Bevacizumab. Until now, we have constructed radiofrequency coils suitable for studying breast tumors implanted on foot and mammary fat pad, optimized SelMQC, SS-SelMQC, and SEE-SelMQC sequences for lactate/choline detection from whole tumors as well as localized 2D slices with high-resolution using phantoms and part of these methods are tested with in vivo MCa-7 tumors.
Document Details
- Document Type
- Technical Report
- Publication Date
- May 01, 2010
- Accession Number
- ADA534912
Entities
People
- Sunitha B. Thakur
Organizations
- Memorial Sloan Kettering Cancer Center